We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FDA Grants Rare Pediatric Disease Designation to Cellceutix’s Kevetrin
FDA Grants Orphan Drug Designation to PhaseBio for Cardiomyopathy Treatment
Advaxis Osteosarcoma Candidate Scores Orphan Drug Designation in EU
Novo Nordisk Acquires Rights to Xoma’s XMetA Program
MHRA Releases Guidance Clarifying Baseline Submissions